Article
A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
American journal of hematology - 1 Nov 2017
Solovey Anna, Somani Arif, Belcher John D, Milbauer Liming, Vincent Lucile, Pawlinski Rafal, Nath Karl A, Kelm Robert J, Mackman Nigel, O'Sullivan M Gerard, Gupta Kalpna, Vercellotti Gregory M, Hebbel Robert P
Abstract excerpt
Elaboration of tumor necrosis factor (TNF) is a very early event in development of ischemia/reperfusion injury pathophysiology. Therefore, TNF may be a prominent mediator of endothelial cell and vascular wall dysfunction in sickle cell anemia, a hypothesis we addressed using NY1DD, S+SAntilles , and SS-BERK sickle transgenic mice. Transfusion experiments revealed participation of abnormally activated blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
